Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: It especially irritates me that since 2009 we have been in a severe cash crunch

while barely surviving the foolish and utterly disasterous M&A adventurism of the BOD. We are repeated warned in filings that we require others to generate revenue for us, that there is limited time left in the patents, that we rely on X, Y and Z for our viability, and that unless N, O, and P occur, that there can be no assurances of continuing operations; etc etc etc.

Yet, even in this highly cautionary and critical environment, an environment formed by the decisionmaking failures and actions/inactions of the BOD, Carl and Gloria have not reduced their BOD fees, and Cliff's salary has been considerably increased and even given large cash bonuses.

When demanded by Shareholders to require them to purchase company stock, they refused. When demanded by Shareholders for them to replace their shoein Plurality method of Voting for BOD seats, they refused ... and on and on it goes.

It's no mystery what non investors, TPL and MMP litigants think about PTSC when they look at our BOD leadership.

Share
New Message
Please login to post a reply